英文論文

2024年

1. Maeda M, Sunaga T, Takenaka Sato M, Hasegawa T, Noma H, Ota E. Efficacy of carbapenems and alternative antimicrobials for treating complicated urinary tract infections caused by third-generation cephalosporin-resistant gram-negative bacteria: A systematic review and meta-analysis of randomised controlled trials. J Infect Chemother. 2024 [Online ahead of print] [PubMed] [Fulltext].
2. Sunaga T, Maeda M,  Saulle R, Matsumura Ng S,  Takenaka Sato M, Hasegawa T, Andrew MN, Noma H, Ota E. Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews. 2024: CD015804.pub2. [PubMed] [Fulltext].
3. Imaizumi T, Hasegawa T, Kosugi T,  Nishiwaki H, Honda H, Tsuruya K, Ito Y, Kuragano T. Management of anemia and prognosis of patients undergoing maintenance peritoneal dialysis: a nationwide cohort study. Perit Dial Int. 2024 [Online ahead of print][PubMed] [Fulltext].
4. Nishiwaki H, Abe Y, Suzuki T, Hasegawa T, Levack WMM, Noma H, Ota E. Erythropoiesis-stimulating agents for preventing acute kidney injury. Cochrane Database of Systematic Reviews. 2024; CD014820.pub2. [PubMed] [Fulltext].
5. Hanafusa N, Abe M, Joki N,  Hoshino J, Kikuchi K, Goto S, Kanda E, Taniguchi M, Nakai S, Naganuma T, Hasegawa T, Miura K, Wada A, Takemoto Y. Annual dialysis data report 2020, JSDT Renal Data Registry. Ren Replace Ther. 2024;10:14. [Fulltext].
6. Ohtsuka H, Tashiro N, Hasegawa T, Nishiwaki H, Ikeda T, Matoba M, Noma H, Ota E, Levack WMM. Multidisciplinary rehabilitation for Parkinson’s disease. Cochrane Database of Systematic Reviews. 2024: CD015742 [PubMed]  [Fulltext].
7. Honda A, Okada Y, Matsushita T, Hasegawa T, Ota E, Noma H, Imai T, Joey Wong. Efficacy of biological agents combined with oral immunotherapy (OIT) for food allergy: a protocol for a systematic review and meta-analysis. BMJ Open. 2024:14(2):e075253  [PubMed]  [Fulltext].
8. Murashima M, Fujii N, Goto S, Hasegawa T, Abe M, Hanafusa N, Fukagawa M, Hamano T. Residual kidney function modifies the effect of cinacalcet on serum phosphorus levels among peritoneal dialysis patients. J Nephrol. 2024;37(4):1137-1139 [PubMed]  [Fulltext].
9. Ikeda T, Tashiro N, Hasegawa T, Nishiwaki H, Ohtsuka H, Matoba M, Noma H, Ota E.  Protein or branched-chain amino acid intake at breakfast for muscle mass gain in older persons: A protocol for systematic review and meta-analysis. Medicine: Case Reports and Study Protocols. 5(1):e00306, January 2024.  DOI: 10.1097/MD9.0000000000000306 [Fulltext].
10. Oikawa M, Nishiwaki H, Hasegawa T, Sasaki S, Yazawa M, Miyazato H, Saka Y, Shimizu H, Fujita Y, Murakami M, Uchida D, Kawarazaki H, Omiya S, Sasai F, Koiwa F, & JOINT-KD Investigators. The association between high-dose allopurinol and erythropoietin hyporesponsiveness in advanced chronic kidney disease. JOINT-KD study. Nephron, 2024;148(7):448-456 [PubMed] [Fulltext].
11. Ichimura T, Sugita H, Hasegawa T, Noma H, Ota E, Toyoda S. First-line systemic therapy for people with extensive-stage small cell lung cancer: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews. 2024; CD015738. [PubMed] [Fulltext].
12. Tsuji K, Sasai H, Kiyohara K, Nakata Y, Nishiwaki H, Ohta T, Ochi E, Takano T, Tatematsu N, Matsuoka YJ, Japan’s cancer survivorship guidelines for exercise and physical activity, Japanese Journal of Clinical Oncology, 2024;, hyae126,[Fulltext].
13. Funada S, Luo Y, Kato H, Yoshioka T, Uno S, Honda K, Akune Y, Goto R. Trends in the integration of medical corporation hospitals in Japan: a national wide longitudinal study between 2017 and 2021. BMC health services research. 2024;24(1):1005. [PubMed] [Fulltext].
14. Yoshioka T, So R, Funada S, Tsutsumi S, Nakaya T, Okubo R, Minami T, Tabuchi T. Association of night-shift work with gambling and problem gambling among workers in Japan: A nationwide cross-sectional study. Addictive behaviors. 2024;156:108071. [PubMed] [Fulltext].
15. Hanafusa N, Henn L, Bieber B, Hasegawa T, Usui T, Robinson B, Karaboyas A, Nangaku M. Erythropoiesis-stimulating agent hyporesponsiveness was associated with worse survival of hemodialysis patients independent of the serum ferritin level. Ther Apher Dial. 2024 [Epub ahead of print]. [PubMed] [Fulltext].

 

2023年

1. Hanafusa N, Abe M, Joki N, Ogawa T, Kanda E, Kikuchi K, Goto S, Taniguchi M, Nakai S, Naganuma T, Hasegawa T, Hoshino J, Miura K, Wada A, Takemoto Y. Annual dialysis data report 2019, JSDT Renal Data Registry. Ren Replace Ther. 2023;9: 47. [Fulltext].
2. Sato Takenaka M, Hasegawa T, Noma H, Sugita H, Ota E. Efficacy and safety of drug therapy for the prevention and treatment of chemotherapy-induced peripheral neuropathy: a protocol for a systematic review and network meta-analysis. BMJ Open. 2023; 13(9):e070645. [PubMed] [Fulltext].
3. Sunaga T, Maeda M,  Hasegawa T, Andrew MN, Noma H, Ota E. Anti‐vascular endothelial growth factor biosimilars for macular degeneration. Cochrane Database of Systematic Reviews. 2023: CD15804. [Fulltext]
4. Tashiro N, Hasegawa T, Nishiwaki H, Ikeda T,  Noma H,  Ota E. Clinical utility of diaphragmatic ultrasonography for mechanical ventilator weaning in adults: A study protocol for systematic review and meta-analysis. Health Sci Rep. 2023; 6(7): e1378. [PubMed] [Fulltext]
5. Suzuki T, Nishiwaki H, Watanabe Y, Abe Y, Noma H,  Ota E, Honda H, Hasegawa T. Outcomes of discontinuing renin-angiotensin system inhibitors: a study protocol for conducting systematic review and meta-analysis. BMJ Open. 2023; 13(5):e070345. [PubMed] [Fulltext].
6. Maeda M, Hasegawa T, Noma H, Ota E. Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis. BMJ Open. 2023; 13(4):e069166. [PubMed] [Fulltext].
7. Gajjar K, Schiemer R, Staley H, Aslam Shiraz, Matsushita T, Hasegawa T, Bryant A, Inoue  E, Egawa, N. Human papillomavirus (HPV) self-sampling to encourage the uptake of cervical screening. Cochrane Database of Systematic Reviews. 2023 [in press].
8. Sugita H, Takenaka Sato M, Hasegawa T, Noma H, Ota E, Toyoda S. Clinical effectiveness of telepharmacy services in patients with non‐communicable diseases in ambulatory care settings (Protocol). Cochrane Database of Systematic Reviews. 2023 [Fulltext].
9. Hasegawa T*, Imaizumi T, Hamano T, Murotani K, Fujii N, Komaba H, Ando M, Maruyama S, Nangaku M, Nitta K, Hirakata H, Isaka Y, Wada T, Fukagawa M  (*corresponding author). Association between serum iron markers, iron supplementation, and cardiovascular morbidity in pre-dialysis chronic kidney disease. Nephrol Dial Transplant. 2023; DOI: 10.1093/ndt/gfad096. [PubMed][Fulltext]
10. Murashima M, Fujii N, Goto S, Hasegawa T, Abe M, Hanafusa N, Fukagawa M, Hamano T. Associations of calcium, phosphate and intact parathyroid hormone levels with mortality, residual kidney function and technical failure among patients on peritoneal dialysis. Clinical Kidney Journal. 2023;16:1957-1964. [PubMed][Fulltext]

 

2022年

1. Matsushita T, Honda A, Hasegawa T, Inoue E, Noma H, Ota E. Regular weighing to prevent excessive gestational weight gain: A study protocol for a systematic review and meta-analysis. Systematic Reviews. 2022; 11, Article number: 104 [PubMed][Fulltext].
2. Koide Y, Kataoka Y, Hasegawa T, Ota E, Noma H. Effect of systemic bisphosphonate administration on patients with periodontal disease: a systematic review and meta-analysis protocol. BMJ　Open. 2022; 4;12(3):e057768. [PubMed] [Fulltext].
3. Hamano T, Imaizumi T, Hasegawa T, Fujii N, Komaba H, Ando M, Nangaku M, Nitta K, Hirakata H, Isaka Y, Wada T, Maruyama S, Fukagawa M. Biopsy-proven CKD etiology and outcomes: Chronic Kidney Disease Japan Cohort (CKD-JAC) study. Nephrol Dial Transplant. 2022; DOI: 10.1093/ndt/gfac134. [PubMed][Fulltext]
4. Nishiwaki H, Abe Y, Hasegawa T, Levack WMM, Noma H, Ota E. Erythropoiesis-stimulating agents for preventing acute kidney injury (Protocol). Cochrane Database of Systematic Reviews. 2022, Issue 5. Art. No.: CD014820. [Fulltext].
5. Hanafusa N, Tu C, Bieber B, Pisoni RL, Robinson B, Hasegawa T, Nangaku M. An Investigation into Possible Sex Differences in Association of Hemoglobin with Survival Among Hemodialysis Patients in the J-DOPPS Cohort. Nephrology. 2022;27:795-803.[PubMed]
6. Hoshino J, Abe M, Hamano T, Hasegawa T, Wada A, Nakai S, Hanafusa N, Masakane I, Nitta K. Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new association. Nephrol Dial Transplant. 2022 Oct 29:gfac297. doi: 10.1093/ndt/gfac297. [Epub ahead of print][PubMed]

 

2021年

1. Hasegawa T*, Nishiwaki H, Ota E, Levack WMM, Noma H (*corresponding author). Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews. 2021; Issue 2. Art. No.: CD013109. [PubMed][Fulltext]
2. Sasaki S, Raita Y, Murakami M, Yamamoto S, Tochitani K, Hasegawa T, Fujisaki K, Fukuhara S. Added value of clinical prediction rules for bacteremia in hemodialysis patients: An external validation study. PLoS One. 2021;16(2):e0247624.  [PubMed][Fulltext]
3. Nishiwaki H, Niihata K, Shimizu S, Shibagaki Y, Yamamoto R, Nitta K, Tsukamoto T, Uchida S, Takeda A, Okada H, Narita I, Isaka Y, Kurita N, and Japan Nephrotic Syndrome Cohort Study group. Incidence and factors associated with prescribing renin-angiotensin-system inhibitors in adult idiopathic nephrotic syndrome: a nationwide cohort study. J Clin Hypertens. 2021; 23(5):999-1007. doi: 10.1111/jch.14224. [Fulltext]
4. Hasegawa T*, Zhao J, Bieber B, Zee J, Pisoni RL, Robinson BM, Hanafusa N, Nangaku M (*corresponding author). Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus. Kidney Blood Press Res. 2021; DOI: 10.1159/000515704[PubMed][Fulltext]
5. Kawanishi K, Nishiwaki H, Kawata N, Omiya S, Inoue Y, Koiwa H. Granulomatosis with polyangiitis in a patient with a thoracic vertebral lesion: a case report. Modern Rheumatology Case Reports. 2021; (in press)
6. Nitta K, Nakai S, Masakane I,  Hanafusa N, Goto S, Taniguchi M, Hasegawa T,  Wada A, Hamano T, Hoshino J, Joki N, Yamamoto K, Miura K, Abe M, Nakamoto H. 2018 annual dialysis data report of the JSDT Renal Data Registry: patients with hepatitis. Renal Replacement Therapy. 2021; 7: 22. [Fulltext]
7. Nitta K, Nakai S, Masakane I,  Hanafusa N, Goto S, Taniguchi M, Hasegawa T,  Wada A, Hamano T, Hoshino J, Joki N, Yamamoto K, Miura K, Abe M, Nakamoto H. Annual dialysis data report of the 2018 JSDT Renal Data Registry: dementia, performance status, and exercise habits. Renal Replacement Therapy. 2021; 7: 41. [Fulltext]
8. Hasegawa T*, Noma H, Hamano T, Abe M, Wada A, Honda H, Ito Y, Masakane I, Nitta K. (*corresponding author). Association between the use of exchange devices for peritoneal dialysis fluids and peritonitis incidence: A nationwide cohort study. Perit Dial Int. 2021; DOI: 10.1177/08968608211051591. [PubMed]
9. Matsushita T, Hasegawa T, Noma H, Ota E, Chou VB, Okada Y. Interventions to increase access to long-acting reversible contraceptives (Protocol). Cochrane Database of Systematic Reviews. 2021; Issue 11. Art. No.: CD014987.[Cochrane][Fulltext]

 

2020年

1. Robinson BM, Morgenstern H, Karaboyas A, Li Y, Bieber BA, Hakim R, Hasegawa T, Jadoul M, Schaeffner E, Vanholder R, Pisoni RL, Port FK. Estimating the Fraction of First-year Hemodialysis Deaths Attributable to Potentially Modifiable Risk Factors: Results from the DOPPS.  Clinical Epidemiology. 2020;12:51-60. [PubMed][Fulltext]
2. Sasaki S, Takada T, Fukuma S, Imamoto M, Hasegawa T, Nishiwaki H, Iida H, Fukuhara S. Screening tool for identifying adults with excessive salt intake among community dwelling adults: a population-based cohort study. Am J Clin Nutr. 2020;111:814-820. [PubMed][Fulltext]
3. Ishiwatari A, Yamamoto S, Fukuma S, Hasegawa T, Wakai S, Nangaku M. Changes in Quality of Life in Older Hemodialysis Patients: A Cohort Study on Dialysis Outcomes and Practice Patterns. Am J Nephrol. 2020;51(8):650-658.[PubMed][Fulltext]
4. Aboulatta L, Sugita H, Wakabayashi H, Noma H, Sasaki T. Comparison of extended versus intermittent infusion of antipseudomonal beta-lactams for the treatment of critically ill patients with respiratory infections: A systematic review and meta-analysis. Int J Infect Dis. 2020;98:41-50. [PubMed][Fulltext]
5. Usui T, Zhao J, Fuller D, Hanafusa N, Hasegawa T, Fujino H, Nomura T, Zee J, Young E, Robinson BM, Nangaku M. Association of Erythropoietin Resistance and Fibroblast Growth Factor 23 in Dialysis Patients: Results from the J-DOPPS Study. Nephrology. 2021; 26: 46– 53. [PubMed][Fulltext]
6. Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K, Nakamoto H. Annual Dialysis Data Report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Renal Replacement Therapy. 2020; 6: 41. [Fulltext]
7. Hoshino J, Abe M, Hamano T, Hasegawa T, Wada A, Ubara Y, Takaichi K, Nakai S, Masakane I, Kosaku N. Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study. BMJ Open Diabetes Research & Care. 2020;8(1):e001642.[PubMed][Fulltext]
8. Sukul N, Karaboyas A, Csomor PA, Schaufler T, Wen W, Menzaghi F, Rayner HC, Hasegawa T, Al Salmi I, Al-Ghamdi SMG, Guebre-Egziabher F, Ureña-Torres PA, Pisoni RL. Self-Reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis Patients. Kidney Medicine. 2020;3(1):42-53.e1. doi: 10.1016/j.xkme.2020.08.011. [Fulltext]
9. Nitta K, Abe M, Masakane I,  Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Wada A, Hamano T, Hoshino J, Joki N, Goto S, Wakasugi M, Yamamoto K, Nakamoto H. Annual dialysis data report 2018, JSDT Renal Data Registry: dialysis fluid quality, hemodialysis and hemodiafiltration, peritoneal dialysis, and diabetes. Renal Replacement Therapy. 2020; 6: 51. [Fulltext]

 

2019年

1. Nishiwaki H,  Hasegawa T*, Koiwa F, Hamano T, Masakane I (*corresponding author). The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry. PLoS ONE. 2019;14(1):e0210533.[PubMed][Fulltext]
2. Hasegawa T*, Sakamaki K, Koiwa F, Akizawa T, Hishida A (*corresponding author). Clinical Prediction Models for Progression of Chronic Kidney Disease to End-Stage Kidney Failure under Pre-dialysis Nephrology Care: Results from the Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol. 2019;23(2):189-198. [PubMed][Fulltext].
3. Maruta Y, Hasegawa T*, Yamakoshi E, Nishiwaki H, Koiwa F, Imai E, Hishida A (*corresponding author). Association between Serum Na-Cl Level and Renal Function Decline in Chronic Kidney Disease: Results from the Chronic Kidney Disease Japan Cohort (CKD-JAC) Study. Clin Exp Nephrol. 2019; 23(2):215-222.  [PubMed][Fulltext]
4. Iida H, Kurita N, Takahashi S, Sasaki S, Nishiwaki H, Omae K, Yajima N, Fukuma S, Hasegawa T, Fukuhara S. The Sukagawa Study Group. Salt intake and body weight correlate with higher blood pressure in the very elderly population: The Sukagawa study. J Clin Hypertens. 2019;21(7):942-949. [PubMed][Fulltext]
5. Nishiwaki H, Sasaki S, Hasegawa T*, Sasai F, Kawarazaki H, Minatoguchi S, Uchida D, Koitabashi K, Ozeki T, Koiwa F (*corresponding author). External validation of the quick Sequential Organ Failure Assessment score for mortality and bacteremia risk evaluation in Japanese patients undergoing hemodialysis: A retrospective multi-center cohort study. BMJ Open. 2019;9(7):e028856. [PubMed][Fulltext]
6. Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Goto S, Wada A, Hamano T, Hoshino J, Joki N, Abe M,  Yamamoto K, Nakamoto H. Annual Dialysis Data Report 2017, JSDT Renal Data Registry. Renal Replacement Therapy. 2019; 5: 53. [Fulltext]

 

2018年

1. Hasegawa T*, Nishiwaki H, Ota E, William MM Levack, Noma H. (*corresponding author). Aldosterone antagonists for people with chronic kidney disease requiring dialysis (Protocol). Cochrane Database of Systematic Reviews. 2018, Issue 8. Art. No.: CD013109.[Cochrane][Fulltext]
2. Nishiwaki H, Fukuma S, Hasegawa T, Kimachi M, Akizawa T, Fukuhara S. Dialysis-related practice patterns among dialysis patients with cancer. Health Sci Rep. 2018: e46.[PubMed][Fulltext]
3. Nishiwaki H, Hasegawa T*, Shinji M, Matsuo F, Watanabe T, Makino H, Koiwa F, Hishida A (*corresponding author). Practice pattern of physician's directions of exercise restriction in patients with chronic kidney disease. Results from the Chronic Kidney Disease Japan Cohort study. Clin Exp Nephrol. 2018; 22(5): 1108-1115. [PubMed][Fulltext]
4. Masakane I, Taniguchi M, Nakai S, Tsuchida K, Goto S, Wada A, Ogata S, Hasegawa T, Hamano T, Hanafusa N, Hoshino J, Minakuchi J,  Nakamoto H. Annual Dialysis Data Report 2015, JSDT Renal Data Registry. Renal Replacement Therapy. 2018; 4: 19. [Fulltext]
5. Kovesdy CP, Matsushita K, Sang Y, Brunskill NJ, Carrero JJ, Chodick G, Hasegawa T, Heerspink HL, Hirayama A, Landman GWD, Levin A, Nitsch D, Wheeler DC, Coresh J, Hallan SI, Shalev V, Grams ME. Serum Potassium and the Risk of Adverse Outcomes Across the Range of Kidney Function: A CKD Prognosis Consortium Meta-Analysis. Eur Heart J. 2018;39(17):1535-1542. [PubMed]
6. Hoshino J, Hamano T, Abe M, Hasegawa T, Wada A, Ubara Y, Takaichi K, Inaba M, Nakai S, Masakane I. Superiority of glycated albumin over hemoglobin A1c in predicting mortality in diabetic hemodialysis patients. Nephrol Dial Transplant. [Epub ahead of print][PubMed]
7. Nishiwaki H, Hasegawa T*, Ikenoue T, Tominaga N, Yazawa M, Kawarazaki H, Shibagaki Y, Yamamoto Y, Fukuma S, Yamazaki S, Fukuhara S (*corresponding author). Association between post-dialysis hemoglobin level and the survival of vascular access. J Vasc Access. 2018;19(1):69-75. [PubMed][Fulltext]
8. Okubo K, Uchida E, Terahara T, Akiyama K, Kobayashi S, Tanaka Y. Efficacy and safety of emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinitis. Allergol Int. [Epub ahead of print].[Fulltext]
9. Niihata K, Takahashi S, Kurita N, Yajima N, Omae K, Fukuma S, Okano T, Nomoto Y, Omori K, Fukuhara S; Sukagawa Study Group* (*collaborators: Hasegawa T, Iida H, Kobayashi S, Sasaki S, Naganuma T, Nishiwaki H, Tominaga R). Association Between Accumulation of Advanced Glycation End-Products and Hearing Impairment in Community-Dwelling Older People: A Cross-Sectional Sukagawa Study. J Am Med Dir Assoc. 2018;19(3):235-239. [PubMed] [Fulltext]
10. Masakane I, Taniguchi M, Nakai S, Tsuchida K, Wada A, Ogata S, Hasegawa T, Hamano T, Hanafusa N, Hoshino J, Goto S, Yamamot K, Minakuchi J,  Nakamoto H. Annual Dialysis Data Report 2016, JSDT Renal Data Registry. Renal Replacement Therapy. 2018; 4: 45. [Fulltext]

 

2017年

1. Rayner H, Larkina M, Wang Graham-Brown MM, van der Veer SN, Ecder T, Hasegawa T, Kleophas W, Bieber B, Tentori F, Robinson, Pisoni RL. International comparisons of prevalence, awareness and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol. 2017;12(12):2000-2007. [PubMed][Fulltext]
2. Hasegawa T*, Zhao J, Duller DS, Bieber B, Zee J, Morgenstern H, Hanafusa N, Nangaku M (*corresponding author). Erythropoietin hyporesponsiveness in dialysis patients: possible role of statins. Am J Nephrol. 2017;46(1):11-17. [PubMed] [Fulltext] [紹介記事]
3. Imaizumi T, Hasegawa T, Nomura T, Sasaki S, Nishiwaki H, Ozeki T, Shimizu H, Minatoguchi S, Yamakawa T, Yazawa M, Uchida D, Kawarazaki H, Miyamoto M, Suzuki T, Koitabashi K, Furusho M, Fujita Y. Association between Staphylococcus aureus bacteremia and hospital mortality in hemodialysis patients with bloodstream infection: a multicenter cohort from Japanese tertiary care centers. Ther Apher Dial. 2017;21(4):354-360. [PubMed]
4. Sasaki S, Hasegawa T*, Kawarazaki H, Nomura A, Uchida D, Imaizumi T, Furusho M, Nishiwaki H, Fukuma S, Shibagaki Y, Fukuhara S (*corresponding author). Development and Validation of a Clinical Prediction Rule for Bacteremia among Maintenance Hemodialysis Patients in Outpatient Settings. PLoS ONE. 2017;12(1):e0169975. [PubMed]
5. Sasaki S, Kawarazaki H, Hasegawa T, Shima H, Naganuma T, Shibagaki Y. Anemia and Long-Term Renal Prognosis in Patients with Post-Renal Acute Kidney Injury of Nonmalignant Cause. Nephron.  2017;135(2):129-136. [PubMed]
6. Masakane I, Hasegawa T, Ogata S, Kimata N, Nakai S, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K. Annual peritoneal dialysis report 2014, the peritoneal dialysis registry. Renal Replacement Therapy. 2017; 3: 21. [Fulltext]
7. Nitta K, Masakane I, Tomo T, Tsuchida K, Ikeda K, Ogawa T, Kanda E, Kanno Y, Komatsu Y, Taniguchi M, Taki F, Hasegawa T, Hanafusa N, Hamano T, Fukagawa M, MInakuchi J, Yamamoto H, Washida N, Wada T, Watanabe Y. Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy. Renal Replacement Therapy. 2017; 3: 34.  [Fulltext]
8. Uchida D, Sasaki S, Kawarazaki H, Miyamoto M, Nomura A, Koitabashi K, Nishiwaki H, Shibagaki Y; Japanese InvestigatOrs with Innovative NeTwork about Kidney Disease (JOINT-KD). Systemic Inflammatory Response Syndrome Is Not an Indicator of Bacteremia in Hemodialysis Patients With Native Accesses: A Multicenter Study. ASAIO J. 2017; 63:501-506. [PubMed]
9. Perl J, Karaboyas A, Morgenstern H, Sen A, Rayner H, Vanholder R, Combe C, Hasegawa T, Finkelstein F, Lopes A, Robinson BM, Pisoni RL, Tentori F. Association between Changes in Quality of Life and Mortality in Hemodialysis Patients: Results from the DOPPS. Nephrol Dial Transplant. 2017;32(3):521-527. [PubMed]

 

2016年

1. Masakane I, Hasegawa T*, Ogata S, Kimata N, Nakai S, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K (*corresponding author). Peritoneal Dialysis Registry with 2013 Survey Report. Ther Apher Dial. 2016;20(6):557-568. [PubMed]
2. Yazawa M, Kido R, Seiji O, Hasegawa T, Hanafusa N, Iseki K, Tsubakihara Y, Shibagaki Y. Early mortality was high and strongly associated with functional status in incident Japanese hemodialysis patients: A cohort study of the large national dialysis registry. PLoS ONE. 2016;11(6): e0156951. [PubMed]
3. Sakao Y, Ojima T, Yasuda H, Hashimoto S, Hasegawa T, Iseki K, Tsubakihara Y, Kato A. Serum creatinine modifies associations between body mass index and mortality and morbidity in prevalent hemodialysis patients. PLoS ONE. 2016;11(3):e0150003. [PubMed]
4. Akizawa T, Kurita N, Mizobuchi M, Fukagawa M, Onishi Y, Yamaguchi T, Ellis A, Fukuma S, Brookhart A, Hasegawa T, Kurokawa K, Fukuhara S. PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism. Scientific Reports.  2016;6:19612. [PubMed]
5. Komukai D, Hasegawa T, Kaneshima N, Takayasu M, Sato Y, Hirose M, Yoshimura Y. Influence of Acute Kidney Injury on the Time to Complete Remission in Adult Minimal Change Nephrotic Syndrome: A Single-Center Study. Nephrology. 2016;21(10):887-892. [PubMed]